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INTRODUCTION 
Primary malignant brain tumours are rarely 
diagnosed in primary care populations as the 
incidence is low: the age-adjusted incidence 
for the commonest type, glioma, is between 
4.7 and 5.7 per 100 000 people.1,2 Outcomes 
remain poor despite improvements in 
treatment, so that, although brain tumours 
represent <2% of all cancers, they result 
in the most life-years lost of any cancer.3,4 
Most patients with primary brain tumours 
have seen their GP before diagnosis, often 
several times,5 and >50% then present to, or 
are diagnosed by, accident and emergency 
services rather than by GPs or in specialist 
settings.6,7 Indeed, in the UK only 1% of 
patients are currently diagnosed via the 
‘suspected cancer’ 2-week wait process, 
and via GP routine referrals,8 despite the 
publication of standardised National Institute 
for Health and Care Excellence guidelines 
in 2006,9 which were updated in 2018,10 and 
some intervening liberalisation of access to 
diagnostic imaging.11 
More timely diagnosis could improve 
patient outcomes, yet patients and GPs 
may find it difficult to recognise the early 
symptoms of brain tumours. In primary care, 
these patients can present with symptoms 
that are far commoner manifestations of 
benign conditions, making the diagnostic 
process very challenging.12 Over the last 
decade, a number of studies have used 
routinely collected English primary care data 
to quantify the frequency of the commoner 
presenting symptoms and their predictive 
values.13–15 However, a systematic review 
found that, apart from new-onset epilepsy 
and headache, these symptoms have low 
positive predictive values for brain tumours: 
even headache has a positive predictive value 
of <1%.16 A recent analysis of 226 brain 
tumour cases from the national audit of 
cancer diagnosis in primary care showed 
that the commonest presentations were 
focal neurology (33%), ‘fits, faints, or falls’ 
(21%), and headache (21%).17 
Little is known about how patients 
appraise possible symptoms of brain 
tumours and make decisions about when, 
why, or how they should seek help. However, 
qualitative research set among patients who 
were referred with possible symptoms of, 
or recently diagnosed with, other cancers 
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Abstract
Background
Brain tumours are uncommon, and have 
extremely poor outcomes. Patients and GPs 
may find it difficult to recognise early symptoms 
because they are often non-specific and more 
likely due to other conditions.
Aim
To explore patients’ experiences of symptom 
appraisal, help seeking, and routes to 
diagnosis.
Design and setting
Qualitative study set in the East and North West 
of England.
Method
In-depth interviews with adult patients recently 
diagnosed with a primary brain tumour 
and their family members were analysed 
thematically, using the Model of Pathways to 
Treatment as a conceptual framework.
Results
Interviews were carried out with 39 patients. 
Few participants (n = 7; 18%) presented 
as an emergency without having had a 
previous GP consultation; most had had 
one (n = 15; 38%), two (n = 9; 23%), or more 
(n = 8; 21%) GP consultations. Participants 
experienced multiple subtle ‘changes’ rather 
than ‘symptoms’, often noticed by others 
rather than the patient, which frequently led 
to loss of interest or less ability to engage 
with daily living activities. The most common 
changes were in cognition (speaking, writing, 
comprehension, memory, concentration, and 
multitasking), sleep, and other ‘head feelings’ 
such as dizziness. Not all patients experienced 
a seizure, and few seizures were experienced 
‘out of the blue’. Quality of communication in 
GP consultations played a key role in patients’ 
subsequent symptom appraisal and the timing 
of their decision to re-consult. 
Conclusion
Multiple subtle changes and frequent GP 
visits often precede brain tumour diagnosis, 
giving possible diagnostic opportunities for 
GPs. Refined community symptom awareness 
and GP guidance could enable more direct 
pathways to diagnosis, and potentially improve 
patient experiences and outcomes.
Keywords
central nervous system neoplasms; diagnosis; 
primary brain neoplasms; primary care; 
symptoms.
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has illuminated aspects of symptom 
appraisal processes.18–21 These include 
patients ‘normalising’ their symptoms if 
they consider them part of an expected 
ageing process, or if symptoms are vague, 
intermittent, or non-threatening. Therefore, 
this study aimed to use similar qualitative 
research methods among patients recently 
diagnosed with a brain tumour to develop a 
richer understanding of their experiences of 
symptoms preceding diagnosis, appraisal of 
these symptoms, help seeking, and routes 
to diagnosis to inform awareness and 
potentially drive service change.
METHOD
Design 
In-depth interviews were conducted face to 
face with adults who had been very recently 
diagnosed (within 4 weeks) with a primary 
brain tumour in the East and North West 
of England. The study was undertaken 
and reported in line with the standards for 
reporting qualitative research.22 
Setting and recruitment
Potential participants were identified 
and recruited by neuro-oncology nurse 
specialists via weekly neurosurgery clinics 
at two regional hospitals: Cambridge 
University Hospitals NHS Foundation Trust 
and the Walton Centre NHS Foundation 
Trust in Liverpool. These hospitals together 
serve a population of approximately 
6 million, and their multidisciplinary team 
meetings review more than 500 new cases 
of primary malignant brain tumours each 
year.
All adults aged ≥18 years who were newly 
diagnosed with a primary brain tumour at 
the two participating hospitals were eligible 
for inclusion unless the neuro-oncology 
nurse specialists felt that they were not 
suitable on clinical grounds (due to severe 
physical or mental health conditions). 
Patients were given or mailed an invitation 
letter with a patient information sheet. 
Purposive sampling strategies were used 
to recruit a range of participants by age, 
sex, and location to ensure a broad range of 
views and experiences, and were continued 
until data saturation was reached. Sampling 
decisions and illness were the main reasons 
for not selecting patients for interview.
Data collection
Semi-structured interviews were carried 
out with patients and their family members 
(usually a spouse or child) in their homes 
between September 2016 and June 2017, 
following their diagnosis and before 
undergoing brain surgery. All present 
gave their written informed consent to 
participate. An experienced researcher 
used an interview topic guide based on 
the aims of the research, the available 
research literature,13,16 and the authors’ 
collective expertise from interviewing 
patients recently diagnosed with other 
cancers.18–21 The guide was piloted, used, 
and revised during the study as new issues 
arose. It focused on when and how initial 
symptoms were noticed; the language used 
to describe symptoms and changes over 
time; the participant’s decision making and 
triggers to help seeking; and experiences 
of the diagnostic process from the patient’s 
perspective. Interviews lasted between 45 
and 90 minutes, and were audiorecorded, 
professionally transcribed verbatim, 
checked, and anonymised. Reflexive field 
notes were made following the interviews.
Analysis
Transcripts were imported to NVivo (version 
11) to support coding and data organisation. 
Inductive thematic analysis commenced 
soon after the beginning of data collection.23 
Each participant-reported patient interval 
(time from first noticing a change to first 
presentation, including the appraisal and 
help-seeking intervals) and diagnostic 
interval (time from first presentation to 
diagnosis) was defined.24 The Model of 
How this fits in
National data suggest that people 
diagnosed with a brain tumour often 
see their GP several times before they 
are investigated or referred, frequently 
present as an emergency, and have 
poor outcomes. The findings from this 
study, in which people were interviewed 
soon after their brain tumour diagnosis, 
suggests that, although some patients 
present with headaches or major seizures, 
most experience subtle, intermittent, 
and multiple changes in their cognitive 
functioning, sleep, and other ‘head feelings’ 
for many months, suggesting possible 
missed diagnostic opportunities. As 
these interviews were undertaken with 
patients and their family members soon 
after diagnosis, potential recall and social 
desirability biases affecting their reported 
experiences should be minimised. Being 
aware of these subtle and intermittent 
changes or symptoms, and effective 
patient–GP communication with follow-up 
as safety netting, could alert GPs to more 
rapid investigation and referral, and possibly 
reduce development of the significant and 
major symptoms associated with brain 
tumours.
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Pathways to Treatment25,26 was then used 
as a conceptual model to underpin the 
remaining analysis. A coding frame based 
on this model was developed with the first 
few transcripts, applied to the subsequent 
transcripts, and refined iteratively, with a 
constant comparative method applied.27 
When the first consultation did not result 
in referral, further iterative processes were 
also included in the analyses. Members of 
the core research team, from a range of 
clinical and non-clinical backgrounds, read 
all the transcripts, and met regularly to 
resolve coding issues, and further refine the 
coding framework. Codes were compared 
within and across interviews, and then 
grouped into key themes and sub-themes. 
These were agreed through a series of 
meetings with the core researchers, the two 
consumer members of the research team, 
and consensus meetings with the wider 
study team, which included neuro-oncology 
experts.
The analysis focused on two main areas. 
The symptoms that patients experienced 
before a brain tumour diagnosis and how 
these were reported and responded to in 
primary care are presented in this article. 
The psychological approaches underpinning 
the appraisal and help-seeking processes, 
often over several consultations, are 
reported elsewhere.28
Workshop: triangulation of early findings
Early findings of this study were shared at a 
workshop supported by the Brain Tumour 
Charity, which included GPs from London 
(n = 10), and patients (n = 7) and carers/
family members (n = 9) affected by brain 
tumours drawn from across England. Four 
mixed and facilitated focus groups were 
undertaken for credibility checking. These 
lasted up to 1 hour each, were audiorecorded, 
transcribed verbatim, checked, anonymised, 
and analysed to search for concordant, 
discordant, or new data. With reference 
to this analysis, the findings were entirely 
supportive, and no new data were found.
RESULTS 
A total of 39 patients were interviewed; their 
mean age was 53 years and 18 (46%) were 
female. The commonest diagnoses were 
glioblastomas, located in the frontal region 
(Table 1). 
Although headache and seizure (without 
preceding symptoms) are generally 
considered to be the most common 
presenting symptoms of brain tumours in 
primary and emergency care, headaches 
and seizures were only reported by half 
the participants (n = 21; 54%). More patients 
reported changes in cognition (n = 26; 67%) 
and sleep (n = 22; 56%). Furthermore, almost 
all participants (n = 38; 97%) had noticed 
multiple changes or symptoms before either 
routine or emergency presentations. 
Four main themes were identified in 
participants’ narratives: people experience 
‘changes’ rather than ‘symptoms’, which 
are often first noticed by others; multiple 
subtle changes precede brain tumour 
diagnosis; not all seizures are the same and 
few come ‘out of the blue’ (that is, without 
any prodrome); and quality of patient–
GP communication. These themes are 
presented in detail below, with quotations 
contextualised with the participant’s ID 
number, sex, and age group.
People experience changes rather than 
symptoms, often first noticed by others
Participants frequently described ‘changes’ 
or ‘something not quite right’ rather than 
‘symptoms’. Some changes related to their 
body, and others to the way they approached 
daily living activities, work, hobbies, or 
relationships (Figure 1). 
Some changes were very subtle and 
difficult to notice; sometimes the participant 
was unaware of a change until someone else 
pointed it out: 
‘I felt OK, I didn’t feel as though there 
was anything wrong with me, but looking 
back now I can see what [my wife] was 
worried about.’ (Participant [P] 30, male [M], 
71–80 years) 
Sometimes friends or family had noticed 
a change, but did not say anything until after 
the participant had been diagnosed:
‘People … wouldn’t say anything at the time 
but now they say, “We noticed you haven’t 
been quite yourself for 6 months”, but they 
are little things that people wouldn’t say, “Go 
to the doctors and get sorted.”’ (P10, female 
[F], 61–70 years)
Multiple subtle changes precede brain 
cancer diagnosis
Figure 1 demonstrates the diverse range 
of changes experienced that made the 
participant think ‘that is not me’ or a person 
close to them report ‘you weren’t quite 
yourself’. 
Experiencing these changes or 
symptoms often led to less engagement, 
less interest in or a change in ability to carry 
out work, hobbies, caring responsibilities, 
and daily living activities. ‘Seizure’ does not 
have a separate locus in Figure 1 as any of 
these changes could precede or be a part 
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of a seizure. These changes are described 
in detail below. To summarise, changes 
were noted in cognitive function (‘brain not 
working properly’, changes in speaking 
and writing, changes in comprehension, 
changes in memory, and changes in 
concentration and ability to multitask); 
in sleep; in how the patient’s head feels 
(‘I wouldn’t say it’s a headache …’ and a 
new or different headache); in balance, 
sensations, and senses (body parts weak 
or not working, changes in vision, changes 
in hearing, and changes in taste or smell); 
and, in the person, being ‘out of character’.
Changes in cognitive function: ‘brain not 
working properly’. People described not 
being able to do things as they used to, or 
being less accurate or not ‘on the ball’: 
‘I could feel myself getting a bit slower in 
work. I was struggling to do and think of all 
the things that I’d normally do … I just knew 
I wasn’t as quick and I couldn’t think ahead 
as much and it just wasn’t the same.’ (P37, 
F, 31–40 years)
Some people noticed very subtle changes, 
whereas others described having to put 
extensive thought into everyday tasks: 
‘If I’m trying to do something, sometimes 
you have to stand there for about 5 to 
10 minutes and figure out how I was going 
to do it.’ (P33, M, 51–60 years)
Cognitive changes often made people feel 
frustrated, irritated, confused, or anxious. 
Participants and their family members 
described four main types of changes in 
cognitive function as outlined below.
Changes in cognitive function: changes in 
speaking and writing. Many participants 
and their family members noticed that 
speech changed, often intermittently. 
Some experienced difficulty finding or 
saying words, whereas others noticed odd 
sentences with random words: 
‘I’m trying to say something … I can think 
it, but it doesn’t really come out. I can’t find 
the right words, really.’ (P39, F, 21–30 years)
Many also mentioned problems with 
spelling, with text messages or emails 
becoming full of errors or lacking sense. 
Participants found texting became more 
difficult and took longer, leading some to 
replace text with emoticons or stop sending 
texts altogether:
‘I’m normally a pretty good speller, but I 
couldn’t remember how to spell words 
Table 1. Characteristics of study participants diagnosed with brain 
tumours
Variable Participants (n = 39) 
 n (%)
Age at interview (mean age = 53 years, range = 22–74)
 21–40 10 (26)
 41–60 15 (38)
 ≥61 14 (36)
Sex
 Male 21 (54)
 Female 18 (46)
Region of England 
 Eastern 30 (77)
 North Western 9 (23)
Patient interval (first symptom to first presentation)a 
 <7 days 5 (13)
 1–4 weeks 3 (8)
 1–6 months 10 (26)
 7–12 months 11 (28)
 >12 months 10 (26)
Diagnostic interval (first presentation to diagnosis)a 
 <7 days 1 (3)
 1–4 weeks 16 (41)
 1–6 months 15 (38)
 7–12 months 5 (13)
 >12 months 2 (5)
Reported consultations with GPs in primary care
 0 7 (18)
 1 15 (38)
 2 9 (23)
 ≥3 8 (21)
Reported consultations with emergency care
 Emergency only (no contact with GP) 7 (18)
 Emergency care with contact with GP 
• GP contact before emergency care 14 (36)
• GP contact after emergency care 1 (3)
• GP contact before and after emergency care 5 (13)
 No emergency care  12 (31)
Tumour type
Diffuse astrocytoma 5 (13)
Anaplastic astrocytoma 4 (10)
Oligodendroglioma 2 (5)
Anaplastic oligodendroglioma 2 (5)
Glioblastoma 22 (56)
Other astrocytic tumours 2 (5)
Unknown 2 (5)
Tumour location 
 Frontal (including frontoparietal × 2) 20 (51)
 Temporal 10 (26)
 Parietal (including parieno-occipital × 2) 4 (10)
 Occipital 2 (5)
 Other (thalamus × 1, tempero-insula × 1, N/A × 1) 3 (8)
WHO gradeb
 Low grade: II 8 (21)
 High grade: III/IV 7/22 (18/56)
 Ungraded 2 (5)
aParticipant account, not confirmed from clinical records. bBrain tumours are graded by the World Health 
Organization (WHO) from 1 –4, according to how they behave. Tumours graded 1 and 2 are slow growing, whereas 
tumours graded 3 and 4 are fast-growing, more aggressive tumours. N/A = not applicable.
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‘I wouldn’t say it’s a headache’
 World of your own
 Strange, weird,
fizzy, foggy, fuzzy,
 funny spell,
 dizzy
Body parts weak or not working
 Vibrating, twitching, shaking
 Pins and needles, tingling, numb
 Burning, heavy
 Can’t move, weak
 Falling, tripping, leaning, misjudging, staggering
  Changes in vision, hearing, taste, or smell
 Sensitivity to noise and smell
 Metallic smell or taste
Blurred, double, or reduced vision
Muffled sound
 Lethargy, ‘just can’t
 be bothered’
 Awkward or
 stressful interactions
 Low mood
 More sensitive
Irritated, angry
New or different headache
 Longer or continuous
 Piercing sharp pain
 More intense
 Painkillers
 Unbearable
Extreme tiredness
 Disrupted sleep
 Sleep more
 Sleep less
 Memory: forgetting
  Not on the ball
 Communication
Comprehension
 Concentration
Hard to multitask
‘Brain not
working
properly’
Work
Changes
in sleep
‘Head feels 
  like …’
Change
in balance,
sensations,
and senses
Changes
in person:
‘out of
character’
Work
Caring responsibilities
Driving
Eating
Writing Reading
Walking
Speaking
Relationships
Hobbies
Errors/crash
Difficulty with directions
Problems changing gear
Need help
Loss of appetite
Messy
Takes longer
Messy handwriting
Gobbledegook text messages
Spelling errors
Wasn’t going in
Had to re-read
Slower
No sense
Can’t find word
Slurring
Less engagement
Change in ability
Loss of interest
‘That is not me’
‘You weren’t
quite yourself’
Figure 1. Changes or symptoms experienced by participants before their brain tumour diagnosis.
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and writing up notes at work was a bit of a 
concern ‘cos I was forgetting how to spell.’ 
(P03, F, 31–40 years)
‘Total gobbledegook, because I pushed the 
wrong key, predictive text. So then I took 
the predictive text off, but then it was even 
worse. It could take me 10 minutes to write 
an email.’ (P32, M, 71–80 years) 
Changes in cognitive function: changes 
in comprehension. Most participants 
noticed a change in their understanding 
or processing of information. Some people 
struggled to understand what was being 
said or how long it would take to complete 
tasks: 
‘I’ve got this catch-up, it takes me a while to 
realise what they’ve said and quite often I’ll 
ask them to repeat it or sometimes it just 
takes longer to have got through.’ (P24, F, 
41–50 years)
The greatest impact was on reading. 
Some patients reported having to frequently 
re-read text or stopped reading altogether:
‘Although I was having trouble reading, 
I was also having trouble understanding 
what the words were saying … I couldn’t 
be bothered to read because even if I could 
read it, I didn’t really understand what it 
was telling me anyway … The plot was 
disappearing every other page.’ (P32, M, 
71–80 years)
Changes in cognitive function: changes in 
memory. Memory was affected in a range 
of situations, including people forgetting 
where they had left objects, what they were 
doing or thinking about in the moment, 
completing tasks as intended, or names 
or places:
‘Probably [for] the last 6 months, they all 
used to laugh at me and just say “Who’s got 
more dementia, you or your mum?”’ (P05, 
F, 41–50 years)
Family (Fa): ‘He kept forgetting things. He 
kept forgetting people’s names. And places. 
He couldn’t remember.’ 
Patient (P): ‘People I’ve known for 40 years, 
I couldn’t remember names. Really couldn’t 
and that’s what really upset me.’ (P33, M, 
51–60 years)
Changes in cognitive function: changes in 
concentration and ability to multitask. Some 
noticed that they were struggling to 
concentrate or focus: 
‘Whereas before that he could get to work 
with his eyes closed basically, he was 
actually questioning himself, “What have I 
got to do next? What am I here for?”, that 
sort of thing. He … kept saying, “I can’t 
concentrate.”’ (P19, M, 61–70 years)
Others found that they could only 
concentrate on one thing at a time, 
and therefore developed difficulty with 
multitasking:
‘I was trying to plait her hair and test her 
on the spellings and I had a funny turn and 
it was just too much, I just couldn’t cope 
with looking, listening, and doing.’ (P37, F, 
31–40 years)
Changes in sleep. For some, sleep became 
disrupted and they often struggled to go to 
sleep, frequently waking up, not sleeping 
well, or waking earlier than usual. Others 
described sleeping more than normal, by 
going to bed earlier or waking up later. 
Some started having daytime naps because 
they felt an urgent need to close their eyes 
and rest, or because their night-time sleep 
was disrupted; these people described 
feelings of extreme tiredness:
‘I’ve literally pulled my car over, closed my 
eyes, and gone to sleep, which is unheard of 
[as] I’ve never found sleep that easy.’ (P03, 
F, 31–40 years)
Fa:‘You always used to go to bed about 
half-past 10 didn’t you? But then that got 
to 8 o’clock didn’t it? … And then just before 
he was really poorly, come half-past 7 
he would say, “I’m going up.”’ (P19, M, 
61–70 years)
‘I mean, I was just, well, tired, exhausted … 
I was feeling absolutely totally shattered.’ 
(P15, M, 51–60 years)
‘Head feels like …’: ‘I wouldn’t say it’s a 
headache …’. Many participants felt 
strange sensations in their heads. Rather 
than calling them a headache or pain, they 
were described as feeling ‘muzzy’, ‘fuzzy’, 
‘thick’, ‘fluttering’, or ‘coming in a wave’. 
Some spoke about temporary feelings of 
dizziness or light-headedness, described as 
‘like being drunk’, and ‘giddy’. One patient 
had experienced such sensations every 
2–3 weeks over the preceding year: 
‘Not dizziness, not losing balance, not 
anything to do with your eyes, just literally 
the sensation of my head doing a little spin.’ 
(P12, F, 51–60 years)
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‘I can only describe it like a sherbet bomb in 
my head … like that fizz bomb you have in the 
bath … but not painful, not uncomfortable, 
not anything … I would lay down and there 
would be a little bit of fizzing. No big deal, 
it wouldn't last forever, but you know, just 
aware of what a strange sensation that is.’ 
(P27, F, 71–80 years)
‘I wouldn’t say it’s a headache, but you get 
like a little pain in the front of your head and 
it goes just like that. It’s almost like a wave.’ 
(P34, M, 41–50 years)
‘Head feels like …’: a new or different 
headache. Many participants spoke about 
having changing headaches such as new-
onset headaches, a headache with increased 
intensity or duration, or one that felt 
different from ‘a normal headache’. Some 
described these headaches as constant 
or daily. Some spoke about experiencing 
painful headaches that were severe and 
unbearable: their pain was described as 
feeling like pressure, pulsations, piercing, 
drilling, and fireworks. Some noted they had 
started taking painkillers regularly:
Fa:‘ ‘Before any of this started, [when] I’ve 
been getting up for work he’ll say, “God, 
I’ve got a terrific headache”, which … you 
never get headaches do you?’ (P30, M, 
71–80 years)
‘Very piercing … they would shoot across the 
back of [my] head or across [my] forehead … 
I could stand there, I hadn’t got a headache, 
all of a sudden, it was like somebody had put 
a needle in [my] head.’ (P13, F, 31–40 years)
‘That was a pretty extreme headache 
because I don’t get headaches, but if I do, 
I really don’t normally need a paracetamol 
just to get through it.’ (P32, M, 71–80 years)
Changes in balance, sensations, and senses: 
body parts weak or not working. Participants 
spoke of weakness or numbness in parts of 
their body, or that body parts ‘just didn’t 
work’. Some experienced sensations such 
as pins and needles, tingling, twitching, or 
shaking in that part of the body, and, for 
some, this was later recognised as resulting 
from a seizure:
‘You know if you have a really dead arm, 
and then the feeling comes back, and it 
sort of prickles and it stings rather like 
stinging nettles, and feels very heavy.’ (P12, 
F, 51–60 years)
‘I always sat here with a roll-up … I did 
notice I was dropping it, it was annoying me 
that I was dropping it.’ (P27, F, 71–80 years)
‘I noticed that I was slurring my words and 
wasn’t able to say some syllables. When 
I was leaving a voicemail message on an 
answer machine, I had to repeat myself to 
get the thing out.’ (P21, M, 51–60 years) 
When these sensations were noticed in 
upper limbs, some found that they dropped 
objects or felt clumsy or unable to hold 
everyday objects. Facial changes could result 
in dribbling, slurred speech, or difficulty 
talking. Weaker lower limbs were mainly 
manifested by slower walking or changes 
in a person’s ability to drive. Participants 
noticed changes in balance or becoming 
unstable. They spoke about leaning to 
one side, wobbling, staggering, tripping, 
stumbling, hovering, and sometimes falling:
Fa:‘ ‘I noticed it because you were walking 
around as if you was about 90 years old, 
you sort of like hunched over and your legs 
were really slow and you were just wobbly 
the whole time.’ 
P: ‘Yes. I could hear my foot drag along the 
ground.’ (P16, M, 61–70 years)
‘I didn’t fall over, I was just a little bit 
unsteady. I can walk normally but not on 
a line, you know like when a policeman 
wants you to walk on a line for being tiddly? 
I couldn’t do that.’ (P11, M, 71–80 years)
Changes in balance, sensations, and senses: 
changes in vision. Some participants 
noticed that their eyesight or ability to 
focus deteriorated, experiencing blurred or 
double vision (sometimes intermittently), 
or were squinting or straining to see. For 
others, their field of vision was reduced, and 
a few participants spoke about experiencing 
a tic in their eye: 
‘You know when you’re dreaming and it’s 
hazy or like you can’t see properly, it’s 
like that … like a blur … It’s more cloudy, 
like a mist comes over my eyes.’ (P06, F, 
31–40 years)
P: ‘I was drifting to the left all the time.’ 
Fa:‘ ‘He were driving right close to other 
cars that were parked or anything that’s 
this side … so I had to keep telling him to 
go back to the middle of the road.’ (P17, M, 
61–70 years)
Changes in balance, sensations, and 
senses: changes in hearing. A few 
participants experienced sensitivity to noise: 
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‘If the kids make a noise upstairs I haven’t 
been able to handle it very well, so I’ve 
noticed a big increase in sensitivity to the 
light and the noise … everything was just 
heightened, the dog barking and things like 
that it would make me very irritable.’ (P03, 
F, 31–40 years)
Others felt their hearing was 
compromised, predominantly on one side, 
as if the sound was muffled or their ear 
was wrapped in cotton wool. Such changes 
meant that these people were straining to 
hear, asking people to repeat what they 
were saying or lip reading: 
‘I found myself kind of turning to hear with 
my good ear and things like that … when my 
colleague speaks to me … she’s further into 
the room … I have to really try and lip read 
what she’s saying. I can still hear but just 
not very well.’ (P23, F, 21–30 years)
Changes in balance, sensations, and 
senses: changes in taste or smell. A few 
participants spoke about a metallic smell 
or taste that was particularly strong at 
times. This was sometimes subsequently 
attributed to a seizure:
‘I had had this funny smell … I don’t know 
if it’s a bit metal-y or a bit fuel-y, maybe 
workshop-y I suppose.’ (P07, F, 31–40 years)
Change in person: ‘out of character’. 
Participants and family members compared 
recent moods, attitudes, or behaviours 
with how the patient had previously been. 
Participants mostly knew they were ‘out 
of character’; some had been apologetic 
for their change, or articulated that they 
did not know why they were acting in a 
different manner. A number of personality 
or emotional changes were mentioned, 
including becoming more irritable, angry, 
anxious, overwhelmed, or sensitive than 
normal:
‘Not being as tolerant and as thoughtful and 
as considerate as I would probably expect 
myself to have been … I thought I was being 
totally irrational and not reasonable, and 
unfair and unkind.’ (P02, M, 51–60 years)
Other changes included lack of social 
inhibitions or change in social interactions:
Fa: ‘It was subtle changes in his personality 
where he was a little bit inappropriate. 
And I’ve never had to worry about that, you 
know, I mean he can be quite outrageous 
when he’s being funny, but it’s within the 
realms of absolutely fine. And then I started 
to worry about what he was going to say, 
who he was going to wind up, yeah, just how 
far he might go.’ (P20, M, 71–80 years)
Some were aware of a sense of lethargy 
that they had not had in the past, describing 
lack of motivation or lack of interest, and 
commonly using the phrase ‘just can’t be 
bothered’ about work and hobbies.
Not all seizures are the same or come 
'out of the blue'
Not all seizures were the same: they 
differed between participants and over time. 
Participants spoke of experiences that were 
‘out of the norm’ and unwanted, yet still 
‘understandable’ such as having déjà vu, 
panic attacks, sleepwalking, or intrusive 
daydreams. 
Participants explained their symptoms 
as a ‘simple’ response to being tired, over-
exercising, or not eating. Symptoms that 
were more intrusive led some participants 
and their family members to think they 
were experiencing a stroke. 
People experiencing a seizure often did 
not seek help initially, and the timing of the 
decision to seek help was often driven by a 
seizure involving a collapse. However, not 
all patients collapsed, and some chose to 
visit their GP rather than the emergency 
department for seizure symptoms:
‘I would feel, “Ooh, that’s a bit strange”, I’m 
just overtired or there’s been a little reaction 
and it just didn’t seem to make sense … 
They were so spasmodic then that it was 
easy to put it down to just being over-tired 
and a bit overwrought at work, really.’ (P02, 
M, 51–60 years)
‘I thought it was like panic attacks … It 
started off with little twitches and obviously, 
you don’t really pay attention but now they’re 
getting like my arm will flare up, my leg will 
twitch up that way.’ (P06, F, 31–40 years)
‘I just thought they were intrusive daydreams 
or funny repetitive thoughts … it was that 
déjà vu sort of thing … I just thought this 
must be some weird baby brain.’ (P07, F, 
31–40 years)
Quality of patient–GP communication
Patients spoke about the considerable 
consequences of subtle differences in 
discourse during GP consultations and 
these were reflected in the patients’, carers’, 
and GPs’ suggestions for how to improve GP 
consultations to reduce missed diagnostic 
opportunities (Box 1).
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Selective or limited disclosure. Patients 
discussed some of the changes or 
symptoms with their GP, but often failed to 
mention all the changes they had noticed 
because they forgot, or were reluctant to give 
more details, or found the consultation too 
short. Some noted that they were uncertain 
about which changes were important to 
discuss: 
‘What did I tell him … I was feeling really 
lousy and what have you … at that point I 
didn’t actually say I’ve just crashed the car 
through … I didn’t.’ (P27, F, 71–80 years)
Fa: ‘You don’t know what information to offer 
the doctor because you don’t know what’s 
relevant and what isn’t. So for [patient] to 
go and not know, you needed someone to 
ask the leading questions … and then put a 
picture together for you. Rather than just sit 
there.’ (P26, F, 41–50 years)
Conversely, some patients were 
prompted by their GP to reveal more details, 
which, in turn, could lead to a decision to 
refer the patient for further investigations:
‘I said, “I’ve got a migraine” and that was 
it, that was pretty much all the information 
I was willing to give and then he said, “OK, 
well what else has been going on?” And 
then he made me go through the past 
4 weeks like what you did and then got 
me to describe the migraine in detail and 
prompted as well.’ (P36, F, 21–30 years) 
Alignment of views. Patients generally 
attended their GP with ideas about the 
cause of their symptoms. Sometimes 
patients felt disappointed when they were 
told nothing was ‘wrong’ yet they continued 
to experience symptoms, and spoke of 
believing they had been ‘fobbed off’ or 
‘brushed off’. In some cases, the GP agreed 
with the patient’s views and subsequent 
investigations aligned with the patient’s 
suggestions. 
However, GPs disagreed with the patient’s 
suggestions in many more instances. A brain 
tumour was not initially considered by the GP 
or the patient; instead, other diagnoses such 
as infection (viral, or ear, nose, and throat), 
hormonal changes (thyroid or menopause), 
eye problems, or mental health issues were 
considered more likely and investigated first. 
Once these diagnoses had been ruled out 
and the patient decided to re-visit their GP, 
a computed tomography scan was more 
likely to be arranged during subsequent 
consultations:
Fa:‘You went to the GP about a month ago 
and said then that you’d been having these 
feelings of not feeling right and not being 
able to articulate your speech and thoughts 
… He did a preliminary dementia test, 
because [patient] was worried that he was 
getting Alzheimer’s.’ (P02, M, 51–60 years)
P: ‘I think I felt a bit fobbed off with it really … 
‘cos [GP] would just look at you and if 
something wasn’t physical or if something 
wasn’t fitting in with what he thinks he just 
didn’t have anything to do with you.’ 
Fa:‘You felt like as if you’ve been brushed 
off.’ (P31, M, 41–50 years)
GP response impacts the patient's decision 
to re-consult. When GPs appraised 
symptoms and gave plausible explanations, 
patients spoke of feeling reassured; 
sometimes this gave patients less incentive 
to re-attend when symptoms continued. 
If patients felt their symptoms were 
dismissed or not given attention by the 
GP, this prompted them to downplay their 
symptoms and, again, their motivation to 
re-consult was low:
‘When I said, “Well, still got the headaches”, 
it didn’t [seem to] matter … So I never went 
back to my doctors, I just took it that they 
were saying that the headaches were OK.’ 
(P05, F, 41–50 years)
‘I was getting to the stage where I thought, 
well maybe it is just something that will 
disappear and, you know, they don’t seem 
too worried about it so I left it for a long 
time.’ (P23, F, 21–30 years)
Some patients spoke about the GP 
specifically asking the patient to return, 
Box 1. Workshop participants’ views on how to improve GP 
consultations to reduce missed diagnostic opportunities
1  Ten-minute appointments or ‘one symptom per appointment’ are not sufficient to share subtle, 
intermittent changes or symptoms, and can lead to selective or limited disclosure.
2  Vague symptoms need thorough exploration by family doctors. Take a good history from family and 
friends if not forthcoming from the patient as patients may not notice all the symptoms themselves.
3  Improve how patients present their symptoms in the consultation (for example, encourage patients to 
bring written lists of symptoms, track multiple symptoms, and voice any concerns).
4  Aim at continuity of care so that GPs can have increased awareness of symptom changes over time. 
5  Encourage follow-up appointments by making them before a patient leaves the surgery or giving a time 
limit for symptoms to resolve. 
6  Empower patients to return if they think something is wrong or if they are unhappy with the plan. 
7  Identify patients with repeated consultations with vague symptoms and have lower threshold for referral 
based on GP intuition. 
8  When ordering investigations, most patients would rather be told that cancer is a differential diagnosis.
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with some booking the appointment for the 
patient. Others felt that there were missed 
opportunities to obtain a quicker diagnosis 
because they were not actively encouraged 
to re-attend if test results were negative, 
or symptoms persisted or developed. A 
few also spoke of long times between 
appointments, slow or forgotten referrals, 
or scan results not being reviewed:
‘Well, I just feel [my doctor] should have 
said, “look, if your eye test comes back 
clear, come back and we’ll have another 
look at you, and we’ll investigate it” … But 
you listen to what your doctor says and 
because they never said come back … I just 
feel they just sort of brush you off.’ (P05, F, 
41–50 years)
‘You think that if you’d got something that is 
progressively carrying on over a long period 
of time that you would get to a stage where 
you think that you would investigate this a 
bit more.’ (P31, M, 41–50 years)
‘She said, “Don’t worry about it too much 
and come back and see me in a little 
bit,” which is fair enough … She made an 
appointment for me to come back I think.’ 
(P07, F, 31–40 years)
‘They didn’t send me to A&E, they sent me 
to a specific clinic where she’d obviously 
rung in front, because they were waiting, 
and a couple of days later, and she only 
works 2 days a week at the surgery, she 
actually phoned up [spouse] to check that 
everything went well. So I suspect when I 
walked in the door, she knew there was a 
problem.’ (P32, M, 71–80 years)
DISCUSSION
Summary
As far as the authors are aware, this is the 
first study to explore patient experiences 
along the pathway to primary brain tumour 
diagnosis. It provides a rich understanding 
of how people and their family and friends 
try to make sense of subtle, intermittent, 
and often multiple changes in their 
functioning and wellbeing before they are 
even identified as ‘symptoms’. 
More than half of the study participants 
and their family members noticed a 
combination of physical and cognitive 
changes more than 6 months before 
seeking help, and many went on to have 
multiple encounters with GPs and other 
healthcare professionals before either 
referral and appropriate diagnostic 
imaging, or accelerating symptoms leading 
to emergency presentation. 
Strengths and limitations 
The study sample was diverse with respect 
to age, type, and stage of brain tumour 
at diagnosis, and was drawn from two 
regions of England characterised by diverse 
socioeconomic circumstances. Importantly, 
patients were interviewed within a few 
weeks of their diagnosis and before 
undergoing neurosurgery, facilitating recall 
of the subtle and intermittent ‘changes’ 
or symptoms they had experienced over 
the preceding months. They were also 
encouraged to have a family member 
present during the interview. Both 
approaches should minimise recall bias. 
The authors believe that data saturation was 
achieved as no new themes were identified 
in the later interviews. Furthermore, the 
workshop for GPs, other patients, and their 
family members provided an opportunity 
to triangulate the analysis and check the 
credibility of the study’s early findings, as 
well as confirming saturation. 
The main limitation was that the 
participants were often unwell when 
they were interviewed, and sometimes 
apprehensive about their imminent major 
surgery. Although they were altruistic 
in wishing to contribute to the current 
research, their condition sometimes led to 
difficulties in communication, or to reliance 
on family members to ‘talk for them’. There 
may have been differences between the 
‘public’ accounts given in the interviews, 
often in front of loved ones, and participants’ 
actual experiences and views. However, this 
work still provides important insights into 
the subtle and intermittent changes that 
can precede a brain tumour diagnosis and 
potential missed diagnostic opportunities.
Comparison with existing literature
These findings are consistent with previous 
work, which shows that non-specific 
symptoms often precede brain tumour 
diagnosis, making patient presentation and 
GP assessment for further investigation or 
referral problematic. This can result in multiple 
GP consultations, emergency presentations, 
and longer patient pathways.17,29
A recently reported epidemiological study, 
which analysed brain tumour cases from the 
national audit of cancer diagnosis in primary 
care, grouped neurological symptoms 
into six domains: headache, behavioural 
or cognitive change, focal neurology, ‘fits, 
faints, and falls’, non-specific neurological, 
and other or non-specific.17 However, the 
current study’s findings have identified a far 
wider range of subtle and often intermittent 
symptoms, more frequently referred to 
as ‘changes’ by the patients, and suggest 
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that the GP case-note audit approach may 
not have identified people presenting with 
changes in sleep, and feelings in their head, 
not identified as a headache. There may 
also be a recording bias in primary care 
records studies because GPs tend to record 
a single symptom or the most significant 
symptoms, and there is neither the time nor 
the codes available to record more subtle or 
complex presentations, or the terms used 
by the patients to describe the changes.
Implications for research and practice 
Clinicians continue to consider seizures and 
headache as the main presenting symptoms 
of brain tumours.30 However, the current 
study has shown that patients notice other 
changes and symptoms for many months 
before presentation. Studies using qualitative 
approaches have contributed to a deeper 
clinical understanding of the development 
of other serious conditions such as 
pancreatic cancer31 and meningococcal 
disease in children.32 Clearly, the current 
study’s qualitative findings, drawn from a 
small sample of patients soon after their 
brain tumour diagnosis, now need to be 
validated in a larger cohort. If generalisable, 
these findings could lead to tailored 
awareness campaigns for adult patients and 
educational approaches for GPs in a similar 
way to the HeadSmart campaign that was 
launched in the UK in 2011, following the 
recognition that the median total diagnostic 
interval was three times longer for children 
with brain tumours in the UK than in the 
US.33 The HeadSmart guidance on symptom 
awareness, assessment, investigation, 
and referral has been shown to enhance 
awareness among health professionals 
and the public, and appears to have led 
to a significant reduction in the UK’s total 
diagnostic interval.33,34
Non-specific early symptoms of brain 
tumours can contribute to diagnostic 
delays and possible disease progression. 
GPs seeing patients with these non-specific 
symptoms, such as mild cognitive changes 
or sleep changes, should be able to identify 
patients who warrant further investigation 
without an increase in unnecessary brain 
imaging, which may expose incidental 
abnormalities. GPs could benefit from a 
triage tool, particularly one that is low cost 
and accessible in primary care, such as 
the GP assessment of cognition (GPCOG) 
screening tool to elicit cognitive and 
functional changes indicative of dementia.35 
A promising new approach is a serum-based 
spectroscopic tool that can detect disease-
specific signatures;36 this has been shown 
to be a potentially cost-effective addition 
to the brain tumour diagnostic pathway,37 
and is currently under development as a 
triage tool for primary care. Furthermore, 
recent advances in molecular biology 
have improved our understanding of 
glioma pathogenesis, with genomics now 
combined with histology in the revised 2016 
World Health Organization classification 
of central nervous system tumours; this 
could contribute to biomarker-based early 
detection of brain tumours in the future.38 
In summary, although subtle and 
intermittent changes or symptoms 
are almost universally experienced with 
age, and may occur with headache, GPs’ 
awareness of the changes preceding brain 
tumour diagnosis, and effective patient–GP 
communication with follow-up as safety 
netting, could alert them to more rapid 
investigation and referral, and possibly 
reduce development of the significant and 
major symptoms associated with brain 
tumours.
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